Secreted Respiratory Syncytial Virus G Glycoprotein Induces Interleukin-5 (IL-5), IL-13, and Eosinophilia by an IL-4-independent Mechanism
Overview
Authors
Affiliations
The attachment glycoprotein G of respiratory syncytial virus (RSV) is produced as both membrane-anchored and secreted forms by infected cells. Immunization with secreted RSV G (Gs) or formalin-inactivated alumprecipitated RSV (FI-RSV) predisposes mice to immune responses involving a Th2 cell phenotype which results in more severe illness and pathology, decreased viral clearance, and increased pulmonary eosinophilia upon subsequent RSV challenge. These responses are associated with increased interleukin-4 (IL-4) production in FI-RSV-primed mice, and the responses are IL-4 dependent. RNase protection assays demonstrated that similar levels of IL-4 mRNA were induced after RSV challenge in mice primed with vaccinia virus expressing Gs (vvGs) or a construct expressing only membrane-anchored G (vvGr). However, upon RSV challenge, vvGs-primed mice produced significantly greater levels of IL-5 and IL-13 mRNA and protein than vvGr-primed mice. Administration of neutralizing anti-IL-4 antibody 11.B11 during vaccinia virus priming did not alter the levels of vvGs-induced IL-5, IL-13, pulmonary eosinophilia, illness, or RSV titers upon RSV challenge, although immunoglobulin G (IgG) isotype profiles revealed that more IgG2a was produced. vvGs-priming of IL-4-deficient mice demonstrated that G-induced airway eosinophilia was not dependent on IL-4. In contrast, airway eosinophilia induced by FI-RSV priming was significantly reduced in IL-4-deficient mice. Thus we conclude that, in contrast to FI-RSV, the secreted form of RSV G can directly induce IL-5 and IL-13, producing pulmonary eosinophilia and enhanced illness in RSV-challenged mice by an IL-4-independent mechanism.
Kawahara E, Senpuku K, Kawaguchi Y, Yamamoto S, Yasuda K, Kuroda E NPJ Vaccines. 2024; 9(1):187.
PMID: 39394212 PMC: 11470036. DOI: 10.1038/s41541-024-00987-w.
The role of respiratory syncytial virus G protein in immune cell infection and pathogenesis.
Anderson J, Do L, van Kasteren P, Licciardi P EBioMedicine. 2024; 107:105318.
PMID: 39217853 PMC: 11402919. DOI: 10.1016/j.ebiom.2024.105318.
Kim M, Chu K, Lee S, Mao J, Eom G, Yoon K Respir Res. 2024; 25(1):7.
PMID: 38178222 PMC: 10765939. DOI: 10.1186/s12931-023-02641-w.
Lee S, Chu K, Kim M, Mao J, Eom G, Yoon K Pharmaceutics. 2023; 15(3).
PMID: 36986643 PMC: 10051362. DOI: 10.3390/pharmaceutics15030782.
Bigay J, Le Grand R, Martinon F, Maisonnasse P Front Microbiol. 2022; 13:932408.
PMID: 36033843 PMC: 9399815. DOI: 10.3389/fmicb.2022.932408.